169 related articles for article (PubMed ID: 33606067)
1. The prognostic implications of chronic kidney disease and anemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
Takeuchi M; Dohi T; Takahashi N; Endo H; Doi S; Kato Y; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Minamino T
Heart Vessels; 2021 Aug; 36(8):1117-1124. PubMed ID: 33606067
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients.
Matsue Y; Matsumura A; Abe M; Ono M; Seya M; Nakamura T; Iwatsuka R; Mizukami A; Setoguchi M; Nagahori W; Ohno M; Suzuki M; Hashimoto Y
Heart Vessels; 2013 Jan; 28(1):19-26. PubMed ID: 22160439
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of preoperative chronic kidney disease and anemia in patients undergoing coronary artery bypass graft surgery.
Ogami T; Matsue Y; Kawasumi R; Tanabe H
Surg Today; 2017 Feb; 47(2):245-251. PubMed ID: 27324394
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
Chernin G; Chen S; Ozan O; Liu M; Haberman D; Perlman G; Ben-Yehuda O; Jonas M
Am J Nephrol; 2019; 50(6):465-472. PubMed ID: 31655801
[TBL] [Abstract][Full Text] [Related]
5. Impact of Chronic Kidney Disease and Anemia on Outcomes After Percutaneous Coronary Revascularization.
Cilia L; Sharbaugh M; Marroquin OC; Toma C; Smith C; Thoma F; Lee J; Mulukutla SR
Am J Cardiol; 2019 Sep; 124(6):851-856. PubMed ID: 31375241
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
Baber U; Farkouh ME; Arbel Y; Muntner P; Dangas G; Mack MJ; Hamza TH; Mehran R; Fuster V
Eur Heart J; 2016 Dec; 37(46):3440-3447. PubMed ID: 27572072
[TBL] [Abstract][Full Text] [Related]
7. Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
Chen H; Spirito A; Sartori S; Nicolas J; Cao D; Zhang Z; Baber U; Kamaleldin K; Guthrie J; Vogel B; Sweeny J; Krishnan P; Sharma SK; Kini A; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2023 Feb; 101(3):511-519. PubMed ID: 36691863
[TBL] [Abstract][Full Text] [Related]
8. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
[TBL] [Abstract][Full Text] [Related]
9. Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
Nishio R; Dohi T; Takeuchi M; Takahashi N; Endo H; Doi S; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
J Cardiol; 2022 Apr; 79(4):509-514. PubMed ID: 34799214
[TBL] [Abstract][Full Text] [Related]
10. The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial.
Milojevic M; Head SJ; Mack MJ; Mohr FW; Morice MC; Dawkins KD; Holmes DR; Serruys PW; Kappetein AP
EuroIntervention; 2018 May; 14(1):102-111. PubMed ID: 29155387
[TBL] [Abstract][Full Text] [Related]
11. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
[TBL] [Abstract][Full Text] [Related]
12. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
Baber U; Li SX; Pinnelas R; Pocock SJ; Krucoff MW; Ariti C; Gibson CM; Steg PG; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Iakovou I; Dangas G; Aquino MB; Sartori S; Chieffo A; Moliterno DJ; Colombo A; Mehran R
Circ Cardiovasc Interv; 2018 Mar; 11(3):e006144. PubMed ID: 29870385
[TBL] [Abstract][Full Text] [Related]
13. Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease.
Tokuda K; Tanaka A; Tobe A; Shirai Y; Kurobe M; Kubota Y; Kunieda T; Miyazaki T; Mizutani K; Furusawa K; Ishii H; Murohara T
J Atheroscler Thromb; 2023 Nov; 30(11):1635-1643. PubMed ID: 36908149
[TBL] [Abstract][Full Text] [Related]
14. Association of Plasma Lipoprotein(a) With Long-Term Adverse Events in Patients With Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
Xu N; Tang XF; Yao Y; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
Am J Cardiol; 2018 Dec; 122(12):2043-2048. PubMed ID: 30477725
[TBL] [Abstract][Full Text] [Related]
15. Hypertension and chronic kidney disease affect long-term outcomes in patients with stable coronary artery disease receiving percutaneous coronary intervention.
Lin MJ; Yang WC; Chen CY; Huang CC; Chuang HY; Gao FX; Wu HP
Sci Rep; 2018 Dec; 8(1):17673. PubMed ID: 30518771
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical impact of serum albumin in coronary artery disease patients with preserved renal function.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):285-290. PubMed ID: 29289574
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
[TBL] [Abstract][Full Text] [Related]
18. Three-year clinical outcome of unprotected left main coronary artery disease patients complicated with chronic kidney disease treated by coronary artery bypass graft versus percutaneous coronary intervention.
Wang X; Zhao J; Wang H; Zhao Y; Fu X
Ir J Med Sci; 2021 Feb; 190(1):89-96. PubMed ID: 32529544
[TBL] [Abstract][Full Text] [Related]
19. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
[TBL] [Abstract][Full Text] [Related]
20. The impact of sex, body mass index and chronic kidney disease on outcomes following percutaneous coronary intervention.
Bimal T; Bhuiyan MR; Fishbein J; Ukrani J; Gandotra P; Selim S; Ong L; Gruberg L
Cardiovasc Revasc Med; 2024 Feb; 59():37-45. PubMed ID: 37604707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
